Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV

By sjmartinez • January 25, 2025

Gentry ZO, McAteer OD, Hamad JL, Moran JA, Kim JT, Marsden MD, Zack JA, Wender PA. Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV. Sci Adv. 2025 Jan 24;11(4):eads1911. doi: 10.1126/sciadv.ads1911. Epub 2025 Jan 24. PMID: 39854456.

Tags: Hematology/Oncology, Infectious Diseases, Publications

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

Kumaraswamy A, Hu YM, Yates JA, Zhang C, Rodansky E, Khokhani D, Flores D, Duan Z, Zhang Y, Tabatabaei S, Slottke R, Ye S, Lara[...]

Predicting subjective sleepiness during auditory cognitive testing using voice signaling analysis

Te TT, Boland MR, Ghadimi S, Dzierzewski JM, Alessi C, Martin JL, Kremen S, Bui AAT, Naeim A, Fung CH. Predicting subjective sleepiness during auditory[...]

Feasibility of cognitive testing and ecological momentary assessments using smartphones in middle aged and older adults with insomnia

Ghadimi S, Ereso J, Kaula AJ, Taptiklis N, Cormack F, Alessi C, Martin JL, Dzierzewski JM, Naeim A, Kremen S, Te T, Fung CH. Feasibility[...]